Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

Artan Biotechnologies LLC has closed a $1 million seed round to support progression of the company’s proprietary mutation-specific codon suppression platform toward first-in-human development.

ARTAN Bio, a longevity biotechnology company based in St. Petersburg, Florida, today announced the close of a $1 million seed round led by company co-founder Michael Torres, Ph.D., following his role ...

Two papers present strong evidence that the codon-anticodon interaction is poised on a tipping point so that, given a nudge, the tRNA can insert the wrong amino acid into the growing polypeptide chain ...